OptumHealth Recalls Nimbus II Plus Infusion Pumps
OptumHealth Care Solutions is recalling Nimbus II Plus infusion pumps due to multiple failure modes, following an InfuTronix recall.
OptumHealth Care Solutions is recalling Nimbus II Plus infusion pumps due to multiple failure modes, following an InfuTronix recall.
The reduction in duration of hospital stays and cost-of-care is driving growth of the home infusion therapy market.
Certain Baxter infusion pumps have been discovered to have multiple cybersecurity vulnerabilities, which the company plans to address.
OptumHealth Care Solutions is recalling Nimbus II Plus infusion pumps due to multiple failure modes, following an InfuTronix recall.
Here, Robert Canfield, director of marketing at Fresenius Kabi USA, LLC, sits down with 24×7 Magazine to discuss the state of the infusion therapy sector and whether concerns about infusion pump security are overblown.
Read MoreInfusion Associates completed the acquisition of Okemos Infusion Center to become their sixth location in Michigan.
Read MoreCarepathRx announced a comprehensive home infusion pharmacy partnership with New York-based academic health system Mount Sinai Health System.
Read MoreCybersecurity professionals are constantly looking for ways to prevent any future device or network breaches
Read MorePAVmed had its PortIO Intraosseous Infusion System implanted in three patients as part of its IRB-approved first-in-human clinical study.
Read MoreBaxter International has issued a Class I recall—the most serious type of recall—for its its Spectrum V8 and Spectrum IQ infusion pumps.
Read MoreThe Ivenix Infusion System includes a large-volume infusion pump, portfolio of administration sets, and infusion management software.